Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic

被引:36
作者
McBain, Ryan K. [1 ]
Cantor, Jonathan H. [2 ]
Jena, Anupam B. [3 ,4 ]
Pera, Megan F. [5 ]
Bravata, Dena M. [5 ]
Whaley, Christopher M. [2 ]
机构
[1] RAND Corp, Boston, MA 22202 USA
[2] RAND Corp, Santa Monica, CA USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Castlight Hlth, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
D O I
10.1007/s11606-021-06660-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1829 / 1831
页数:3
相关论文
共 6 条
[1]  
[Anonymous], 2015, COMM CANC TYP
[2]  
Castlight Health, 2020, CASTL HLTH HLTH NAV
[3]  
Chemaly RF, 2020, ONCOLOGIST
[4]  
IBM Watson Health, 2018, MED EP GROUP APPL ME
[5]   Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care [J].
Jones, Daniel ;
Neal, Richard D. ;
Duffy, Sean R. G. ;
Scott, Suzanne E. ;
Whitaker, Katriina L. ;
Brain, Kate .
LANCET ONCOLOGY, 2020, 21 (06) :748-750
[6]  
Nelson B, 2020, BMJ-BRIT MED J, P369